Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TANGO: Tocilizumab vs Azathioprine in NMOSD
NCT03350633Phase 3Completed
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Nov 2017
- Primary completion
- Sep 2019
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by Tianjin Medical University General Hospital. Started Nov 2017; status: completed.
02
Drugs
tocilizumab
03
Conditions
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Beyond the preview
Go deeper on NCT03350633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03350633.